New Vaccine Technology in Development for Severe Diarrhea
Medical Xpress1 min read53 words
Research led by the University of Bergen (UiB) and NORCE may help pave the way for a new vaccine targeting one of the world's leading causes of severe diarrheal disease. The technology has now been licensed to the international vaccine company Valneva, which will take the work forward toward a potential future vaccine.
🤖 AI-generated content — This article was automatically summarised from public RSS feeds by AutoBrief. Verify important information with the original source.